Dasa Janousek

Minimal Residual Disease Values Discriminate Between Low and High Relapse Risk in Children With B-Cell Precursor Acute Lymphoblastic Leukemia and an Intrachromosomal Amplification of Chromosome 21: The Austrian and German Acute Lymphoblastic Leukemia Berlin-Frankfurt-Münster (ALL-BFM) Trials

Andishe Attarbaschi, Georg Mann, Renate Panzer‐Grümayer et al. · Journal of Clinical Oncology · 2008 · 111 citations · Full text

Medicine, Hematology, Oncology +17

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable <i>MYCN</i>-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

Inge M. Ambros, GianPaolo Tonini, Ulrike Pötschger et al. · Journal of Clinical Oncology · 2020 · 31 citations · Full text

Medicine, Bioinformatics, Oncology +11

Prognostic relevance of <i>TLX3 (HOX11L2)</i> expression in childhood T‐cell acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Münster (BFM) protocols containing early and late re‐intensification elements

Andishe Attarbaschi, Markus Pisecker, Andrea Inthal et al. · British Journal of Haematology · 2009 · 23 citations · Full text

Medicine, Hematology, Immunology +11

Prognostic relevance of dic(9;20)(p11;q13) in childhood B‐cell precursor acute lymphoblastic leukaemia treated with Berlin‐Frankfurt‐Münster (BFM) protocols containing an intensive induction and post‐induction consolidation therapy

Herbert Pichler, Anja Möricke, Georg Mann et al. · British Journal of Haematology · 2010 · 19 citations

Medicine, Hematology, Oncology +14